These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8977737)

  • 21. A randomized comparison of 4 weeks of terbinafine vs. 8 weeks of griseofulvin for the treatment of tinea capitis.
    Fuller LC; Smith CH; Cerio R; Marsden RA; Midgley G; Beard AL; Higgins EM; Hay RJ
    Br J Dermatol; 2001 Feb; 144(2):321-7. PubMed ID: 11251566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kerion--a case report.
    Urbanek M; Neill SM; Miller JA
    Clin Exp Dermatol; 1995 Sep; 20(5):413-4. PubMed ID: 8593720
    [No Abstract]   [Full Text] [Related]  

  • 23. A randomized, double-blind, parallel-group, duration-finding study of oral terbinafine and open-label, high-dose griseofulvin in children with tinea capitis due to Microsporum species.
    Lipozencic J; Skerlev M; Orofino-Costa R; Zaitz VC; Horvath A; Chouela E; Romero G; Gourmala N; Paul C;
    Br J Dermatol; 2002 May; 146(5):816-23. PubMed ID: 12000378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tinea capitis update: a continuing conflict with an old adversary.
    Chen BK; Friedlander SF
    Curr Opin Pediatr; 2001 Aug; 13(4):331-5. PubMed ID: 11717558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Failure of terbinafine treatment in 2 children with tinea capitis].
    Stolz E
    Ned Tijdschr Geneeskd; 1996 Sep; 140(36):1833. PubMed ID: 8927153
    [No Abstract]   [Full Text] [Related]  

  • 26. [Failure of terbinafine treatment in 2 children with tinea capitis].
    Strobos MA; Oranje AP
    Ned Tijdschr Geneeskd; 1996 Aug; 140(31):1611-2. PubMed ID: 8768817
    [No Abstract]   [Full Text] [Related]  

  • 27. Management of tinea capitis. A status report.
    Del Rosso JQ; Gupta AK
    Postgrad Med; 1999 Jul; Spec No():38-45. PubMed ID: 10492665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and safety of terbinafine in children.
    Gupta AK; Cooper EA; Lynde CW
    Dermatol Clin; 2003 Jul; 21(3):511-20. PubMed ID: 12956204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of the use of terbinafine (Lamisil) in children.
    Jones TC
    Br J Dermatol; 1995 May; 132(5):683-9. PubMed ID: 7772471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis.
    Haroon TS; Hussain I; Mahmood A; Nagi AH; Ahmad I; Zahid M
    Br J Dermatol; 1992 Feb; 126 Suppl 39():47-50. PubMed ID: 1543673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short duration treatment with terbinafine for tinea capitis caused by Trichophyton or Microsporum species. The Study Group.
    Hamm H; Schwinn A; Bräutigam M; Weidinger G
    Br J Dermatol; 1999 Mar; 140(3):480-2. PubMed ID: 10233270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tinea capitis due to Microsporum audouinii in Malta.
    Vella Zahra L; Vella Briffa D
    Mycoses; 2003; 46(9-10):433-5. PubMed ID: 14622396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral terbinafine in tinea capitis in children.
    Gruseck E; Splanemann V; Bleck O; Ring J; Abeck D
    Mycoses; 1996; 39(5-6):237-40. PubMed ID: 8909037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tinea capitis and tinea corporis with a severe inflammatory response due to Trichophyton tonsurans.
    Hryncewicz-Gwóźdź A; Beck-Jendroschek V; Brasch J; Kalinowska K; Jagielski T
    Acta Derm Venereol; 2011 Oct; 91(6):708-10. PubMed ID: 21710105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized double-blind comparative study of terbinafine for 1, 2 and 4 weeks in tinea capitis.
    Haroon TS; Hussain I; Aman S; Jahangir M; Kazmi AH; Sami AR; Nagi AH; Alvi KH; Iqbal N; Khan KA; Aziz R
    Br J Dermatol; 1996 Jul; 135(1):86-8. PubMed ID: 8776365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tinea capitis in adults.
    Aste N; Pau M; Biggio P
    Mycoses; 1996; 39(7-8):299-301. PubMed ID: 9009649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Terbinafine: efficacy and tolerability in young children with tinea capitis due to Microsporum canis.
    Silm H; Karelson M
    J Eur Acad Dermatol Venereol; 2002 May; 16(3):228-30. PubMed ID: 12195561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of terbinafine in young children treated for tinea capitis.
    Abdel-Rahman SM; Herron J; Fallon-Friedlander S; Hauffe S; Horowitz A; Rivière GJ
    Pediatr Infect Dis J; 2005 Oct; 24(10):886-91. PubMed ID: 16220086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of a 1-week, once-daily regimen of terbinafine 1% cream in the treatment of tinea cruris and tinea corporis.
    Zaias N; Berman B; Cordero CN; Hernandez A; Jacobson C; Millikan L; Rojas R; de la Rosa I; Villars V; Birnbaum JE
    J Am Acad Dermatol; 1993 Oct; 29(4):646-8. PubMed ID: 8408803
    [No Abstract]   [Full Text] [Related]  

  • 40. Terbinafine.
    Shwayder T
    J Am Acad Dermatol; 1998 Jul; 39(1):136. PubMed ID: 9674414
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.